ACRX - AcelRx Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Assets
Current Assets
Cash
Cash And Cash Equivalents
87,975
52,902
80,310
107,922
Short Term Investments
17,740
7,567
0
5,542
Total Cash
105,715
60,469
80,310
113,464
Net Receivables
49
1,533
5,833
3,286
Inventory
854
956
2,154
466
Other Current Assets
-
0
0
0
Total Current Assets
107,994
63,413
89,053
118,947
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
20,427
19,489
17,448
13,464
Accumulated Depreciation
-8,944
-8,438
-6,736
-4,854
Net property, plant and equipment
11,483
11,051
10,712
8,610
Equity and other investments
-
-
-
-
Goodwill
-
-
-
-
Intangible Assets
-
-
-
-
Other long-term assets
705
385
228
228
Total non-current assets
12,539
12,139
10,940
8,838
Total Assets
120,533
75,552
99,993
127,785
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
8,611
7,727
2,912
4,541
Accounts Payable
2,070
1,424
1,558
1,561
Taxes payable
-
-
-
-
Accrued liabilities
929
1,353
2,039
1,080
Deferred revenues
315
362
362
2,604
Other Current Liabilities
392
604
764
118
Total Current Liabilities
15,928
13,660
10,191
12,780
Non-current liabilities
Long Term Debt
3,380
11,369
18,637
16,381
Deferred taxes liabilities
-
-
-
-
Deferred revenues
3,148
3,463
3,824
593
Other long-term liabilities
93,287
83,191
72,347
63,760
Total non-current liabilities
100,352
98,401
95,139
81,892
Total Liabilities
116,280
112,061
105,330
94,672
Stockholders' Equity
Common Stock
78
51
45
45
Retained Earnings
-345,019
-297,870
-246,362
-203,205
Accumulated other comprehensive income
-
-
3
-1
Total stockholders' equity
4,253
-36,509
-5,337
33,113
Total liabilities and stockholders' equity
120,533
75,552
99,993
127,785